KANJINTI vs ORA-TESTRYL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 15, 2026·How we rate

Possible drug interaction. KANJINTI and ORA-TESTRYL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KANJINTI	ORA-TESTRYL
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TRASTUZUMAB-ANNS	FLUOXYMESTERONE
Manufacturer	Amgen Inc	Bristol Myers Squibb
Dosage forms	Injectable	Tablet
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Angioedema, Breast Neoplasms, Hypogonadism

kanjinti ora-testryl

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

TRASTUZUMAB-ANNS

FLUOXYMESTERONE

Manufacturer

Amgen Inc

Bristol Myers Squibb

Dosage forms

Injectable

Tablet

Drug class

—

Boxed warning

None

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Angioedema, Breast Neoplasms, Hypogonadism

Frequently asked questions

Which is better-rated, Kanjinti or Ora-Testryl?

Kanjinti and Ora-Testryl are tied at 3.6 out of 5 by our independent rating.

What is the difference between Kanjinti and Ora-Testryl?

Kanjinti contains Trastuzumab-Anns, while Ora-Testryl contains Fluoxymesterone — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.